logo-loader
NASDAQ:ITRM

Iterum Therapeutics Plc

Receive alerts
Market:
NASDAQ
Market Cap:
$55.76 m
Price
3.75 USD
Change
-7.18%
52 weeks high
7.50
52 weeks low
1.50

In brief

Headquartered in Dublin, Ireland, Iterum is a clinical-stage pharmaceutical company dedicated to developing significantly differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world.